| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.37 | 5e-18 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.31 | 1e-16 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-09 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.21 | 5e-05 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |